03.12.2012 • News

CEO Ton Büchner Returns to AkzoNobel

The Supervisory Board of AkzoNobel is delighted to announce that CEO Ton Büchner will resume his duties on Friday, December 7, following a full recovery.

"On behalf of the Supervisory Board and the Executive Committee we welcome Ton coming back to the office. It has obviously been a testing time for all of us but now Ton is back as expected, leading the company forward and returning to business as usual," said Karel Vuursteen, Chairman of the Supervisory Board.

AkzoNobel will organize an analyst conference call and media interviews on Friday, December 14. Supervisory Board member Antony Burgmans, and CEO Ton Büchner will answer questions relating to this announcement.

On February 20, 2013, AkzoNobel will announce its Q4 and Full Year 2012 results, and Ton Büchner will give the Strategy Update, postponed from October 22.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.